[HTML][HTML] Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu, T Yamashita - Frontiers in Immunology, 2020 - frontiersin.org
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
[引用][C] Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu… - Frontiers in Immunology …, 2020 - jglobal.jst.go.jp
Rüb U, Schöls L, Paulson H, Auburger G, Kermer P, Jen JC, et al. Clinical features,
neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3 …
neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3 …
Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
[HTML][HTML] Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu, T Yamashita - Frontiers in Immunology, 2020 - frontiersin.org
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
[HTML][HTML] Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
[PDF][PDF] Immunotherapies in Huntington's disease and α-Synucleinopathies
O Fatoba, Y Ohtake, T Itokazu, T Yamashita - academia.edu
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
Immunotherapies in Huntington's disease and α-Synucleinopathies.
O Fatoba, Y Ohtake, T Itokazu… - Frontiers in …, 2020 - europepmc.org
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …
Immunotherapies in Huntington's disease and α-Synucleinopathies.
O Fatoba, Y Ohtake, T Itokazu… - Frontiers in …, 2020 - europepmc.org
Modulation of immune activation using immunotherapy has attracted considerable attention
for many years as a potential therapeutic intervention for several inflammation-associated …
for many years as a potential therapeutic intervention for several inflammation-associated …